Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63 CHF | +1.20% | -5.19% | -14.58% |
Jun. 05 | DOCMORRIS : Jefferies gives a Buy rating | ZD |
Jun. 04 | DOCMORRIS : Receives a Sell rating from UBS | ZD |
Sales 2024 * | 1.18B 1.32B | Sales 2025 * | 1.58B 1.77B | Capitalization | 812M 909M |
---|---|---|---|---|---|
Net income 2024 * | -83M -92.93M | Net income 2025 * | -24M -26.87M | EV / Sales 2024 * | 0.9 x |
Net Debt 2024 * | 252M 282M | Net Debt 2025 * | 284M 318M | EV / Sales 2025 * | 0.69 x |
P/E ratio 2024 * |
-9.36
x | P/E ratio 2025 * |
-35.1
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.22% |
Latest transcript on DocMorris AG
1 day | +1.20% | ||
1 week | -5.19% | ||
Current month | -6.32% | ||
1 month | -23.12% | ||
3 months | -15.55% | ||
6 months | +0.88% | ||
Current year | -14.58% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Hess
CEO | Chief Executive Officer | 59 | 14-12-31 |
Founder | 66 | 93-04-05 | |
Marcel Ziwica
DFI | Director of Finance/CFO | 49 | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 10-03-31 | |
Florian Seubert
BRD | Director/Board Member | 51 | 19-05-22 |
Founder | 66 | 93-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +4.32% | - | |
0.00% | 25 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 63 | +1.20% | 83,310 |
24-06-04 | 62.25 | -7.16% | 191,660 |
24-06-03 | 67.05 | -0.30% | 58,259 |
24-05-31 | 67.25 | -0.81% | 81,589 |
24-05-30 | 67.8 | +2.03% | 135,892 |
Delayed Quote Swiss Exchange, June 05, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.58% | 873M | |
-38.95% | 13.9B | |
-32.35% | 10.68B | |
-16.27% | 7.12B | |
+10.79% | 6.24B | |
-11.61% | 5.96B | |
+73.30% | 4.72B | |
-3.50% | 4.56B | |
-8.36% | 3.87B | |
-19.80% | 3.17B |
- Stock Market
- Equities
- ROSE Stock